Smart M195 humanized monoclonal antibody: Phase II/III trials update

M195 alone is in Phase II/III trials in AML and in Phase II trials in acute promyelocytic leukemia, as well as in earlier studies at high doses and in combination with IL-2. (New Zenapax data, see Cl...